Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

SEOVF SERNOVA CORPORATION

0.610
-0.026-4.09%
Close 09/29 16:00 ET
High
0.624
Open
0.624
Turnover
18.18K
Low
0.603
Pre Close
0.636
Volume
29.80K
Market Cap
178.81M
P/E(TTM)
Loss
52wk High
1.756
Shares
293.12M
P/E(Static)
Loss
52wk Low
0.603
Float Cap
178.81M
Bid/Ask %
0.00%
Historical High
1.756
Shs Float
293.12M
Volume Ratio
0.97
Historical Low
0.603
Dividend TTM
--
Div Yield TTM
--
P/B
5.81
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.01%
Amplitude
3.39%
Avg Price
0.609
Lot Size
1
Float Cap
178.81M
Bid/Ask %
0.00%
Historical High
1.756
Shs Float
293.12M
Volume Ratio
0.97
Historical Low
0.603
Dividend TTM
--
P/B
5.81
Dividend LFY
--
Turnover Ratio
0.01%
Amplitude
3.39%
Avg Price
0.609
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
Sernova Corp. is a clinical stage regenerative medicine company. It engages in the business of developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including hemophilia and other diseases treated through replacement of proteins and hormones missing within the body. The firm also focuses in the manufacture and clinical evaluation of the cell pouch for insulin-dependent diabetes. The company was founded on August 19, 1998 and is headquartered in London, Canada.
CEO: Dr. Philip M. Toleikis
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...